Glowing 'Cornell Dots': Potential cancer diagnostic tool set for human trials
Monday, June 13, 2011 - 21:30
in Health & Medicine
The US Food and Drug Administration (FDA) has approved the first clinical trial in humans of a new technology: Cornell Dots, brightly glowing nanoparticles that can light up cancer cells in PET-optical imaging.